How Can Radiopharmaceutical Therapies Reach Their Full Potential? Improving Dose Reporting and Phase I Clinical Trial Design

被引：8
|
作者：
Kiess, Ana P. [1 ]
O'Donoghue, Joseph [2 ]
Uribe, Carlos [3 ,4 ]
Bodei, Lisa [5 ]
Hobbs, Robert F. [1 ]
Hesterman, Jacob [6 ]
Kesner, Adam L. [2 ]
Sgouros, George [7 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, 401 N Broadway,Ste 1440, Baltimore, MD 21231 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY USA
[3] BC Canc, Funct Imaging, Vancouver, BC, Canada
[4] Univ British Columbia, Dept Radiol, Vancouver, BC, Canada
[5] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY USA
[6] Ratio Therapeut Inc, Boston, MA USA
[7] Johns Hopkins Med Inst, Dept Radiol, Baltimore, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 15期
关键词：
RESISTANT PROSTATE-CANCER; NORMAL-TISSUE; NEUROENDOCRINE TUMORS; RADIONUCLIDE THERAPY; RADIATION-DOSIMETRY; LU-177-DOTATATE; TOLERANCE; TOXICITY; KIDNEY; PRRT;
D O I：
10.1200/JCO.23.01241
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：9
相关论文
共 23 条
  • [21] Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery
    Ghilezan, M
    Yan, D
    Liang, J
    Jaffray, D
    Wong, J
    Martinez, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (05): : 1602 - 1610
  • [22] Can Clinical and Functional Outcomes Be Improved with an Intelligent “Internet Plus”-Based Full Disease Cycle Remote Ischemic Conditioning Program in Acute ST-elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention? Rationale and Design of the i-RIC Trial
    Yu Zheng
    Jan D. Reinhardt
    Jianan Li
    Dayi Hu
    Song Lin
    Liansheng Wang
    Ruozhu Dai
    Zhiqing Fan
    Rongjing Ding
    Leilei Chen
    Liang Yuan
    Zhihui Xu
    Yihui Cheng
    Chengjie Yan
    Xintong Zhang
    Lu Wang
    Xiu Zhang
    Meiling Teng
    Qiuyu Yu
    Aimei Yin
    Xiao Lu
    Cardiovascular Drugs and Therapy, 2022, 36 : 45 - 57
  • [23] Can Clinical and Functional Outcomes Be Improved with an Intelligent "Internet Plus"-Based Full Disease Cycle Remote Ischemic Conditioning Program in Acute ST-elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention? Rationale and Design of the i-RIC Trial
    Zheng, Yu
    Reinhardt, Jan D.
    Li, Jianan
    Hu, Dayi
    Lin, Song
    Wang, Liansheng
    Dai, Ruozhu
    Fan, Zhiqing
    Ding, Rongjing
    Chen, Leilei
    Yuan, Liang
    Xu, Zhihui
    Cheng, Yihui
    Yan, Chengjie
    Zhang, Xintong
    Wang, Lu
    Zhang, Xiu
    Teng, Meiling
    Yu, Qiuyu
    Yin, Aimei
    Lu, Xiao
    CARDIOVASCULAR DRUGS AND THERAPY, 2022, 36 (01) : 45 - 57
123